Ad is loading...
RNWHX
Price
$79.89
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
TEMPX
Price
$8.23
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

RNWHX vs TEMPX

Header iconRNWHX vs TEMPX Comparison
Open Charts RNWHX vs TEMPXBanner chart's image
American Funds New World R5E
Price$79.89
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq Prem
Price$8.23
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RNWHX vs TEMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWHX vs. TEMPX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWHX is a Buy and TEMPX is a Sell.

FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 61.7B vs. TEMPX (1.69B). TEMPX pays higher dividends than RNWHX: TEMPX (3.05) vs RNWHX (1.44). RNWHX was incepted earlier than TEMPX: RNWHX (9 years) vs TEMPX (14 years). RNWHX is a more actively managed with annual turnover of: 32.00 vs. TEMPX (14.00). TEMPX has a lower initial minimum investment than RNWHX: TEMPX (0) vs RNWHX (250). RNWHX annual gain was more profitable for investors over the last year : 11.50 vs. TEMPX (8.50). RNWHX return over 5 years is better than : 17.73 vs. TEMPX (-22.89).
RNWHXTEMPXRNWHX / TEMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years14 years-
Gain YTD7.8432.747286%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets61.7B1.69B3,647%
Annual Yield % from dividends1.443.0547%
Returns for 1 year11.508.50135%
Returns for 3 years-11.39-24.5546%
Returns for 5 years17.73-22.89-77%
Returns for 10 yearsN/A-15.72-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBM222.407.80
+3.63%
International Business Machines Corp
ESAB125.463.45
+2.83%
ESAB Corp
PLBY1.150.02
+1.77%
PLBY Group
KAR19.840.18
+0.92%
OPENLANE
YMAB10.10-0.44
-4.17%
Y-mAbs Therapeutics